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ABSTRACT 
Purpose: We studied the effect of polysaccharides on interactions between calcium oxalate 
monohydrate (COM) crystals and cultured renal cells. 
Materials and Methods: Monolayers of Madin-Darby canine kidney (MDCK) cells were incu- 
bated with radiolabeled crystals in the presence of various concentrations of natural glycosami- 
noglycans (GAGS) and semisynthetic polysaccharides (SSPs). 
Results: While most GAGs were found to have relatively little effect, SSPs (SP54, G871 and 
G872) were potent inhibitors of crystal-cell association. Pretreatment of crystals, but not of cells, 
was similarly effective, suggesting polysaccharide-induced modification of crystal surface prop- 
erties. 
Conclusions: This result further supports the idea that SSPs, and especially G872, are of 
potential interest for treatment of recurrent stone disease. 
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Urinary supersaturation, crystal growth and agglomera- 
tion and crystal retention are considered important factors in 
the pathogenesis of calcium oxalate nephrolithia~is.l-~ Crys- 
tal retention could be caused by physical entrapment as a 
result of increased particle size, disturbed urinary flow, or 
adhesion to the brush border of renal tubular cells.4 Several 
investigators have reported on the attachment and subse- 
quent interaction of calcium oxalate crystals with renal tu- 
bular cells in culture.5.6 The possible role of glycosaminogly- 
cans (GAGS) in crystal-cell interaction has not yet been fully 
investigated. Urinary GAGs are found to be potent inhibitors 
of crystallization.'-" Metabolic disorders resulting in a mod- 
ification of the characteristics of urinary GAGs could play a 
role in renal stone disease. Several GAGs are known to occur 
in urine; these include hyaluronic acid (HA), chondroitin-4- 
sulfate (CS-A), dermatan sulfate (CS-B), chondroitin-6-sul- 
fate (CS-C), heparan sulfate (HS) and keratan sulfate 
In addition, GAGs are also present at the apical 
surface of renal tubule cells where they are linked as polysac- 
charide side-chains to the core proteins of plasma membrane 
associated proteoglycans.7 It has been suggested that these 
cell surface constituents in uroepithelial cells provide a pro- 
tective layer that prevents retention of crystals.8.9 Consider- 
ing the relatively high turnover of the cell surface coat, shed- 
ded GAGs may constitute a major fraction of the urinary 
GAG pool. Since the inhibitory activity of crystallization in 
the urine of recurrent stone formers is often dec r sa~ed ,~  it 
has been suggested that oral administration of synthetic 
polysaccharides could contribute to the prevention of stone 
formation by increasing the overall urinary inhibitory activ- 
ity.1.2. In cooperation with the Ocean University of 
Qindao, China, our institute investigates the potential use of 
a group of synthetic polysaccharides (SSPs) derived from 
marine algae.'. 1'). 11.12 These substances have been shown to 
be powerful inhibitors of crystal growth and agglomeration. 
This paper describes the effect of various polysaccharides on 
calcium oxalate monohydrate (COM) crystal-cell interaction. 
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MATERIALS AND METHODS 
Cell culture. Madin-Darby canine kidney (MDCK cells), 
strain 11, were obtained from the American Type Culture 
Collection (ATCC, Rockville, Maryland) and used between 
passage numbers 30 and 50. The cells were cultured in Dul- 
becco's modified MEM supplemented with 10% fetal calf se- 
rum, 20 mM. HEPES, 2 mM. L-glutamine, 100 IU/ml. peni- 
cillin and 100 pg./ml. streptomycin. The medium was 
refreshed every 2 days. The cells were routinely grown in 
plastic tissue culture flasks (Costar, Badhoevedorp, The 
Netherlands) a t  37C in a humidified atmosphere of 5% CO, 
in air. Subculturing was performed weekly with 0.05% tryp- 
sin/0.02% EDTA (GIBCO-BRL, United Kingdom). When cul- 
tured in a 2-compartment culture system on 24-mm. porous 
cell culture inserts with a 0.4 pm. pore size (Costar), MDCK 
cells form polarized monolayers. Cells were seeded at a den- 
sity of 1 x lo6 cells per insert. Although closed monolayers 
were formed within 2 days, the cells were cultured for an 
additional period of time to allow full expression of differen- 
tiated characteristics. Crystal-cell interaction studies were 
performed 8 days after the cells were seeded.13 
Preparation of calcium oxalate crystal suspensions. A solu- 
tion of radioactive oxalic acid was prepared by adding 1 ml. 
0.01 mCi./ml. (0.37 MBq/ml.) [14C]oxalic acid (4.03 GBq/ 
mmol., Amersham International, Little Chalfont, Bucking- 
hamshire, United Kingdom) to 0.5 ml. 200 mM. sodium ox- 
alate. A calcium chloride solution was prepared by adding 0.5 
ml. 200 mM. calcium chloride to 8 ml. distilled water. The 
two solutions were mixed at room temperature, resulting in a 
final concentration of 10 mM. for both calcium and oxalate, 
and [14C]-labeled CaOx crystals with an  average size of 2.03 
~m.13 were formed immediately. The crystal suspension was 
allowed to equilibrate for 3 days. The crystals were then 
washed 3 times with (sodium and chloride-free) CaOx satu- 
rated distilled water, resuspended and stored in 5 ml. of this 
solution. The radioactive crystal suspension contained 2.92 
mg. CaOx crystals per ml. X-ray diffraction of the crystals 
was studied with an X-ray generator PW 1729/00 connected 
to an Integratodhterface PW 1842 (Philips, Eindhoven, The 
Netherlands), and demonstrated that they consisted exclu- 
sively of calcium oxalate monohydrate (COM). 
Crystal-cell interaction studies. Crystal-cell interaction 
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was studied in a CaOx saturated buffer (buffer B) that was 
prepared by the addition of an excess COM crystals (3  mg./ 
ml.) to a buffer (pH 6.7) containing (in mM.): 118 NaC1, 5.3 
KCl, 1.8 CaCl,, 6.6 NaHCO,, 1.3 MgSO,, 2.0 NaH,PO, and 
20 HEPES. The cells were washed and preincubated with 
HEPES buffered serum-free DMEM and added to the apical 
compartment facing the luminal plasma membrane and the 
basal compartment facing the contraluminal plasma mem- 
brane. After 1 hour, 1.5 ml. buffer B was added to the apical 
compartment and 2.6 ml. fresh serum-free DMEM to the 
basal compartment. Polysaccharides were added a t  the api- 
cal side of the monolayers. Subsequently, 50 ~ 1 .  of the crystal 
suspension (146 g.), prepared as described above, was dis- 
tributed homogeneously on top of the cells. After an incuba- 
tion period of 60 minutes, the monolayers were rinsed in 3 
successive buffer B baths to remove nonassociated crystals. 
The filter inserts were cut out with a scalpel and transferred 
to a scintillation vial. To extract radioactivity, 1 ml. 1 M. 
perchloric acid was added and the amount of radioactivity 
was counted in a liquid scintillation counter (Packard, Meri- 
den, Connecticut). The results were calculated as dpm per 
filter and expressed as percentage crystal-cell association 
compared with untreated controls. The inhibitory activity of 
the various polysaccharides was expressed as IC-50 value, 
which represents the concentration that results in a 50% 
inhibition compared with untreated controls. 
To investigate whether polysaccharides interacted with 
the cells, the monolayers were incubated with the compound 
of interest in a volume of 1.5 ml. for periods of 5 minutes to 
48 hours. After this treatment the monolayers were rinsed 3 
times with PBS, and crystal-cell interaction was studied as 
described. To investigate whether polysaccharides interacted 
with the crystal surface, the compound of interest was added 
to the crystal suspension (146 pg. crystals in 1.5 ml. buffer 
B). After 5 minutes the suspension was centrifuged, the 
supernatant removed and the crystals washed 3 times with 
fresh buffer B. Washed crystals were resuspended in fresh 
polysaccharide-free buffer B and crystal-cell interaction stud- 
ies performed as described. 
Polysaccharides. G871 and G872," semisynthetic sulfated 
polyguluronic propionates, extracted from marine algae and 
prepared through physicochemical modification, were kindly 
provided by Professor Guan Hua-Shi, director of the Institute 
of Food and Drugs, Ocean University of Qingdao, China. 
Pentosan polysulfate (SP541, a semisynthetic oligosaccharide 
obtained after the sulfation of a naturally occurring xylan 
composed of repeating 6-D- 1->4-xylopyranose residues, was 
provided by Bene Artzneimittel GmbH (Miinchen, Germany). 
Glycosaminoglycans are naturally occurring highly nega- 
tively charged linear polysaccharides. They consist of repeat- 
ing disaccharide units of alternating hexosamine and hexu- 
ronic acid residues. Heparin (porcine intestinal mucosa), 
heparan sulfate (bovine kidney), chondroitin sulfate-A (bo- 
vine trachea), CS-B (bovine mucosa), CS-C (shark cartilage) 
and hyaluronic acid (human umbilical cord) were obtained 
from Sigma Chemical Co. (St. Louis, Missouri). 
Statistics. All experiments were performed a t  least 2 times. 
The results are presented as means ? SD of 3 independent 
filters. Statistical analysis was performed with a one-way 
analysis of variance (ANOVA) or Student's t test. Differences 
were considered significant a t  p < 0.05. 
Heparin, the most effective natural polysaccharide, inhibits 
COM-crystal interaction with MDCK cells for about 90% a t  a 
concentration of 25 pg./ml. (fig. 1). The SSPS tested exhibited 
strong inhibitory activity a t  much lower concentrations. 4 1  3 
semisynthetic compounds had a statistically significant in- 
hibitory effect (ANOVA, p < 0.05) on the association of COM- 
crystals in a range of 0.01 to 2.0 pg./ml. (fig. 2). The IC-50 
values derived from the curves shown in figures 1 and 2, are 
listed in table 1. The most potent inhibitor was (2872. The 
inhibitory effect of G872 on crystal-cell interaction a t  concen- 
trations of 0.5 and 2 pg./ml. was significantly stronger than 
that of G871 and SP54 a t  these concentrations (fig. 2). 
To investigate whether the inhibitory effects of polysaccha- 
rides on crystal-cell interaction are caused by alterations of 
the cell surface, of the crystal surface, or both, cells and 
crystals were individually treated prior to the determination 
of their interaction. Based on the data shown in figures 1 and 
2, concentrations of G872 (2 pg./ml.) and heparin (25 pg./ml.) 
were selected with comparable inhibitory effects on crystal- 
cell interaction (10 f 2 and 18 f 3% of control, see table 2). 
Pretreatment of the cells for 5 minutes or 1, 24, or 48 hours 
by either compound did not cause significant inhibition of 
interaction with crystals (table 2). The same result was ob- 
tained with CS-B, HS, or SP54 (data not shown). In contrast, 
preincubation of the crystal suspension (followed by exten- 
sive washing as described in Materials and Methods and 
without subsequent addition of polysaccharides) resulted in 
an inhibitory effect that was of the same order of magnitude 
as the inhibition obtained in the continuous presence of these 
compounds (23 f 3 and 15 2 3% of control, see table 2). 
DISCUSSION 
The association of CaOx crystals with renal tubular cells 
could be an early event in the pathogenesis of nephrolithia- 
sis. After induction of hyperoxaluria and subsequent crystal- 
luria it has been found that crystals are retained in the renal 
tubules of rats.14.15 Scanning electron microscopic images 
demonstrated that CaOx crystals were tightly attached to 
the luminal surface of renal tubular cells in a patient with 
hyperoxaluria.16 In patients with primary hyperoxaluria who 
received a kidney transplant, postoperative biopsies revealed 
the presence of CaOx crystals within renal tubular cells.17 
We have previously characterized a model system in which 
the association of CaOx crystals with MDCK monolayers was 
investigated by using radioactively labeled COM-crystals. l 3  
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RESULTS 
Crystal-cell interaction studies were performed in the pres- 
ence of various polysaccharides. In the group of naturally 
occumng GAGs, HA and CS-C in concentrations as great as 
100 kg./ml. did not exhibit an inhibitory effect that is signif- 
icantly different from untreated controls. A concentration- 
dependent statistically significant inhibitory effect was ob- 
served with H, HS, CS-A and CS-B (ANOVA, p < 0.05). 
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FIG. 1. Effect of glycosaminoglycans on interaction of COM CWS- 
tals with MDCK cells (HA. hyaluronic acid; CS-A,B,C: chondroitjn 
sulfate-A,B,C; HS: heparan sulfate; H: heparin ). Statistically signif- 
icant trend is observed with H, HS, CS-A and CS-B (ANOVA, 
p c0.05, n = 3). *Significant difference between H and other 
GAGs (Student's t test, p <0.001, n = 3).  
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FIG. 2. Effect of semisynthetic polysaccharides (SP54, G871 and 
GS72) on interaction of COM crystals with MDCK cells. Statistically 
significant trend with H, HS, CS-A and CS-B (ANOVA, p ~ 0 . 0 5 ,  
n = 3). Significant difference between G872 and other SSPs (Stu- 
dent's t test, p <0.001, n = 3). 
TABLE 1. IC-50 (pg. /ml.) of polysaccharides in COM crystal-cell 
interaction inhibition 
GAGs 
hyaluronic acid 
heparan sulfate 
chondroitin sulfate-A 
chondroitin sulfate-B 
chondroitin sulfate-C 
>loo 
>loo 
> 100 
1100 
> 100 
heparin 3.1 
SSPs 
SP54 
G87 1 
GR72 
2.0 
1.8 
0.6 
TABLE 2 Effect of continuous exposure with and preincubation to 
polysaccharides on cqstal-cell interaction. Data expressed relative 
to the amount of crystals associated with untreated controls (100%) 
Continuous Pretreated Pretreated 
Exposure Cells Crystals 
( % )  ( % I  ( % I  
Heparin 25 pg./ml. 10 z 2 106 2 3 23 2 3 
G872 2 pg./ml. 18 ? 3 95 2 2 15 i 3 
Monolayer-associated radioactivity represents crystals at- 
tached to the cell surface as well as endocytosed crystals.'" 
The present study was initiated to reveal the possible inhib- 
itory effect of naturally occurring and synthetic polysaccha- 
rides on crystal-cell association. Having confirmed such an 
inhibitory activity, it was shown that interaction of polysac- 
charides with the crystal surface, rather than with the cell 
surface accounted for the observed effect. 
I t  was demonstrated in a previous study" using a constant 
composition crystallization model and a seeded crystal 
growth system that G871, G872 and SP54 (10 pg./ml.) exhib- 
ited strong inhibitory effects on COM-crystal growth and 
agglomeration in artificial urine and were capable of shifting 
the COM particle zeta potential in the negative direction. 
G872 had a significantly greater effect than either G871 01 
sP54 on all the measured parameters." The present study 
showed that SSPs are also potent inhibitors of crystal-cell 
interaction, with IC-50 values ranging from 0.6 to 2.0 pg./ml, 
(table 1). Again G872 was the most effective compound. Nat- 
urally occurring GAGs had only limited efficacy in this sys- 
h n  (fig. 1). Only relatively high concentrations of HS, CS-A 
a d  CS-B (100 pg./ml.) resulted in some protection of the 
cells against the interaction with COM-crystals. The only 
naturally occurring polysaccharide that exhibits a consider- 
able inhibitory activity was heparin. However, heparin is 
normally not present in human urine. Although other natu- 
ral GAGs are excreted in the urine (average amount 2 25 mg. 
per d a y P  and contribute to the overall urinary inhibitory 
activity,l-3 the results from this study indicate that, in this 
concentration, these substances do not seem to play an im- 
portant role in the prevention of crystal retention. Neverthe- 
less, it cannot be excluded that natural GAGs may confer 
anticrystal adherence properties on the cell surface. Being 
the polysaccharide side-chains of membrane-associated pro- 
teoglycans, GAGs constitute a negatively charged hydrophyl- 
lic layer that binds water molecules and thereby protects the 
cell membrane against direct contact with circulating mate- 
rial. Free GAGs from the incubation medium, however, will 
not be readily incorporated into such a structure because the 
assembly of proteoglycans is a complex intracellular process. 
Inhibition of crystal-cell interactions by polysaccharides was 
also reported from studies with rat bladder.8.9 Glycosamin- 
oglycans at the surface of rat bladder epithelium were found 
to act as natural barriers against the adherence of crystals. 
Damage of the mucous layer resulted in increased CaOx 
crystal retention, which could be reduced by the administra- 
tion of heparin or SP54.8 Gill et al.9 demonstrated that, in 
contrast to heparin, CS-C and HA could not prevent CaOx 
crystal adhesion to the chemically injured rat bladder. The 
presence of cell surface GAGs, located chiefly at  the apical 
plasma membrane, was also demonstrated in kidney cells,7 
including MDCK cells. 19 
The fact that SSPs are effective in inhibiting crystal 
growth and agglomeration as well as crystal-cell interaction 
suggests that treatment of recurrent stone formers with 
these compounds could contribute to the prevention of stone 
formation. However, in preliminary clinical studies, SP54 
proved ineffective as a treatment for recurrent stone formers, 
largely because of its limited urinary excretion after oral 
administration.20 Preliminary studies in our institute have 
suggested that G872 may prove more useful than SP54 since 
its urinary excretion seems to be higher after oral adminis- 
tration (unpublished observation). 
In conclusion, G871 and G872 are potent inhibitors of the 
interaction of COM crystals with MDCK cells, and their 
inhibitory activity seems to be mediated by their ability to 
alter crystal properties. Although it cannot be excluded that 
the observed effects of polysaccharides in this study are spe- 
cific for our model system, they could also reflect a general 
mechanism of action. To test this hypothesis, animal exper- 
iments are underway in our laboratory to further investigate 
the possible value of these compounds in the treatment of 
recurrent renal CaOx stone disease. 
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